INTEGRA LIFESCIENCES HOLDINGS CORP Capital Expenditures
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Capital Expenditures of $27.16 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-07-29
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $12.31M, a 38.91% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $14.85M, a 48.66% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $17.21M, a 41.84% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $15.16M, a 48.88% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire property, plant, and equipment for fiscal 2025 was $81.44M, a 22.01% decline from fiscal 2024.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire property, plant, and equipment for fiscal 2024 was $104.42M, a 56.16% increase from fiscal 2023.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire property, plant, and equipment for fiscal 2023 was $66.86M, a 57.91% increase from fiscal 2022.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire property, plant, and equipment for fiscal 2022 was $42.34M, a 11.83% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $12.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $27.16M 10-Q · filed 2026-07-29 | $44.37M derived: sum of 3 quarters · filed 2026-07-29 | $59.52M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2026-03-31 | $14.85M 10-Q · filed 2026-05-05 | $32.06M derived: sum of 2 quarters · filed 2026-05-05 | $47.22M derived: sum of 3 quarters · filed 2026-05-05 | $67.36M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-12-31 | $17.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $32.37M derived: sum of 2 quarters · filed 2026-02-26 | $52.52M derived: sum of 3 quarters · filed 2026-07-29 | $81.44M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $15.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $35.30M derived: sum of 2 quarters · filed 2026-07-29 | $64.22M 10-Q · filed 2025-10-30 | $93.82M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | $20.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $49.07M 10-Q · filed 2026-07-29 | $78.67M derived: sum of 3 quarters · filed 2026-07-29 | $108.31M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-03-31 | $28.92M 10-Q · filed 2026-05-05 | $58.52M derived: sum of 2 quarters · filed 2026-05-05 | $88.17M derived: sum of 3 quarters · filed 2026-05-05 | $117.87M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $29.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $59.25M derived: sum of 2 quarters · filed 2026-02-26 | $88.95M derived: sum of 3 quarters · filed 2026-02-26 | $104.42M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $29.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $59.35M derived: sum of 2 quarters · filed 2025-10-30 | $74.82M 10-Q · filed 2025-10-30 | $99.35M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $29.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $45.17M 10-Q · filed 2025-07-31 | $69.71M derived: sum of 3 quarters · filed 2026-02-26 | $82.78M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $15.46M 10-Q · filed 2025-05-05 | $40.00M derived: sum of 2 quarters · filed 2026-02-26 | $53.08M derived: sum of 3 quarters · filed 2026-02-26 | $68.63M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $24.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $37.61M derived: sum of 2 quarters · filed 2026-02-26 | $53.16M derived: sum of 3 quarters · filed 2026-02-26 | $66.86M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $13.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $28.63M derived: sum of 2 quarters · filed 2024-11-04 | $42.33M 10-Q · filed 2024-11-04 | $56.79M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | $15.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-29 | $29.25M 10-Q · filed 2024-07-29 | $43.71M derived: sum of 3 quarters · filed 2025-02-25 | $52.86M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | $13.70M 10-Q · filed 2024-05-06 | $28.16M derived: sum of 2 quarters · filed 2025-02-25 | $37.31M derived: sum of 3 quarters · filed 2025-02-25 | $46.72M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | $14.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $23.61M derived: sum of 2 quarters · filed 2025-02-25 | $33.02M derived: sum of 3 quarters · filed 2025-02-25 | $42.34M 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | $9.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | $18.56M derived: sum of 2 quarters · filed 2023-10-25 | $27.89M 10-Q · filed 2023-10-25 | $55.31M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | $9.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $18.73M 10-Q · filed 2023-07-27 | $46.16M derived: sum of 3 quarters · filed 2024-02-28 | $53.45M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-03-31 | $9.32M 10-Q · filed 2023-04-26 | $36.75M derived: sum of 2 quarters · filed 2024-02-28 | $44.04M derived: sum of 3 quarters · filed 2024-02-28 | $50.67M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | $27.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $34.71M derived: sum of 2 quarters · filed 2024-02-28 | $41.35M derived: sum of 3 quarters · filed 2024-02-28 | $48.02M 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | $7.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-26 | $13.92M derived: sum of 2 quarters · filed 2022-10-26 | $20.59M 10-Q · filed 2022-10-26 | $29.02M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | $6.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $13.31M 10-Q · filed 2022-07-27 | $21.74M derived: sum of 3 quarters · filed 2023-02-22 | $28.46M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | $6.67M 10-Q · filed 2022-04-27 | $15.10M derived: sum of 2 quarters · filed 2023-02-22 | $21.83M derived: sum of 3 quarters · filed 2023-02-22 | $29.05M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $8.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $15.15M derived: sum of 2 quarters · filed 2023-02-22 | $22.37M derived: sum of 3 quarters · filed 2023-02-22 | $38.89M 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | $6.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $13.94M derived: sum of 2 quarters · filed 2021-11-02 | $30.46M 10-Q · filed 2021-11-02 | $52.66M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | $7.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $23.74M 10-Q · filed 2021-07-29 | $45.93M derived: sum of 3 quarters · filed 2022-02-24 | $59.52M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | $16.52M 10-Q · filed 2021-04-29 | $38.71M derived: sum of 2 quarters · filed 2022-02-24 | $52.31M derived: sum of 3 quarters · filed 2022-02-24 | $69.97M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | $22.19M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $35.79M derived: sum of 2 quarters · filed 2022-02-24 | $53.45M derived: sum of 3 quarters · filed 2022-02-24 | $69.54M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | $13.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $31.26M derived: sum of 2 quarters · filed 2020-10-29 | $47.34M 10-Q · filed 2020-10-29 | $73.03M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-06-30 | $17.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $33.75M 10-Q · filed 2020-08-10 | $59.44M derived: sum of 3 quarters · filed 2021-02-23 | $76.10M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2019-03-31 | $16.09M 10-Q · filed 2020-05-07 | $41.77M derived: sum of 2 quarters · filed 2021-02-23 | $58.44M derived: sum of 3 quarters · filed 2021-02-23 | $78.44M derived: sum of 4 quarters · filed 2021-02-23 | ||||
| 2018-12-31 | $25.68M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $42.35M derived: sum of 2 quarters · filed 2021-02-23 | $62.35M derived: sum of 3 quarters · filed 2021-02-23 | $77.74M 10-K · filed 2021-02-23 | ||||
| 2018-09-30 | $16.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | $36.67M derived: sum of 2 quarters · filed 2019-10-25 | $52.06M 10-Q · filed 2019-10-25 | $65.75M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-06-30 | $20.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $35.39M 10-Q · filed 2019-07-25 | $49.08M derived: sum of 3 quarters · filed 2020-02-21 | $56.88M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-03-31 | $15.39M 10-Q · filed 2019-04-29 | $29.08M derived: sum of 2 quarters · filed 2020-02-21 | $36.88M derived: sum of 3 quarters · filed 2020-02-21 | $49.70M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2017-12-31 | $13.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $21.49M derived: sum of 2 quarters · filed 2020-02-21 | $34.31M derived: sum of 3 quarters · filed 2020-02-21 | $43.50M 10-K · filed 2020-02-21 | ||||
| 2017-09-30 | $7.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $20.61M derived: sum of 2 quarters · filed 2018-11-01 | $29.81M 10-Q · filed 2018-11-01 | $51.00M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | $12.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $22.01M 10-Q · filed 2018-07-26 | $43.20M derived: sum of 3 quarters · filed 2019-02-26 | $50.18M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | $9.19M 10-Q · filed 2018-04-26 | $30.38M derived: sum of 2 quarters · filed 2019-02-26 | $37.36M derived: sum of 3 quarters · filed 2019-02-26 | $45.62M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | $21.19M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $28.17M derived: sum of 2 quarters · filed 2019-02-26 | $36.43M derived: sum of 3 quarters · filed 2019-02-26 | $47.33M 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | $6.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $15.24M derived: sum of 2 quarters · filed 2017-10-26 | $26.14M 10-Q · filed 2017-10-26 | $39.23M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | $8.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | $19.16M 10-Q · filed 2017-07-26 | $32.26M derived: sum of 3 quarters · filed 2018-03-01 | $37.62M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | $10.89M 10-Q · filed 2017-04-26 | $23.99M derived: sum of 2 quarters · filed 2018-03-01 | $29.36M derived: sum of 3 quarters · filed 2018-03-01 | $38.98M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | $13.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $18.46M derived: sum of 2 quarters · filed 2018-03-01 | $28.08M derived: sum of 3 quarters · filed 2018-03-01 | $33.41M 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | $5.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $14.98M derived: sum of 2 quarters · filed 2016-10-28 | $20.31M 10-Q · filed 2016-10-28 | $31.55M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | $9.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $14.95M 10-Q · filed 2016-07-28 | $22.01M 10-Q · filed 2015-07-31 | $26.18M derived: sum of 3 quarters · filed 2017-02-23 | $32.60M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2015-03-31 | $5.33M 10-Q · filed 2016-04-27 | $8.90M 10-Q · filed 2015-05-01 | $16.56M derived: sum of 2 quarters · filed 2017-02-23 | $22.98M derived: sum of 3 quarters · filed 2017-02-23 | $32.34M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2014-12-31 | $11.23M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $17.65M derived: sum of 2 quarters · filed 2017-02-23 | $27.00M derived: sum of 3 quarters · filed 2017-02-23 | $38.34M 10-K · filed 2017-02-23 | $41.92M 10-K · filed 2015-02-27 | |||
| 2014-09-30 | $6.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $15.77M derived: sum of 2 quarters · filed 2015-11-04 | $27.11M 10-Q · filed 2015-11-04 | $29.47M 10-Q · filed 2014-11-07 | $31.69M derived: sum of 4 quarters · filed 2016-02-26 | |||
| 2014-06-30 | $9.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $20.69M 10-Q · filed 2015-07-31 | $25.27M derived: sum of 3 quarters · filed 2016-02-26 | $38.52M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $11.34M 10-Q · filed 2015-05-01 | $15.91M derived: sum of 2 quarters · filed 2016-02-26 | $29.16M derived: sum of 3 quarters · filed 2016-02-26 | $42.78M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $4.58M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $17.83M derived: sum of 2 quarters · filed 2016-02-26 | $31.45M derived: sum of 3 quarters · filed 2016-02-26 | $42.30M 10-K · filed 2016-02-26 | $47.85M 10-K · filed 2014-02-27 | |||
| 2013-09-30 | $13.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $26.87M derived: sum of 2 quarters · filed 2014-11-07 | $37.72M 10-Q · filed 2014-11-07 | $62.39M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | $13.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $24.48M 10-Q · filed 2014-08-05 | $49.15M derived: sum of 3 quarters · filed 2015-02-27 | $68.86M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | $10.85M 10-Q · filed 2014-05-01 | $35.52M derived: sum of 2 quarters · filed 2015-02-27 | $55.24M derived: sum of 3 quarters · filed 2015-02-27 | $69.47M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | $24.67M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $44.39M derived: sum of 2 quarters · filed 2015-02-27 | $58.62M derived: sum of 3 quarters · filed 2015-02-27 | $69.03M 10-K · filed 2015-02-27 | ||||
| 2012-09-30 | $19.72M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-10-30 | $33.95M derived: sum of 2 quarters · filed 2013-10-30 | $44.36M 10-Q · filed 2013-10-30 | $57.40M derived: sum of 4 quarters · filed 2014-06-20 | ||||
| 2012-06-30 | $14.23M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2013-08-02 | $24.64M 10-Q/A · filed 2013-08-02 | $37.69M derived: sum of 3 quarters · filed 2014-06-20 | $49.93M derived: sum of 4 quarters · filed 2014-06-20 | ||||
| 2012-03-31 | $10.41M 10-Q · filed 2013-05-02 | $23.46M derived: sum of 2 quarters · filed 2014-06-20 | $35.70M derived: sum of 3 quarters · filed 2014-06-20 | $42.91M derived: sum of 4 quarters · filed 2014-06-20 | ||||
| 2011-12-31 | $13.04M derived: 8-K 12 month − 10-Q 9 month · filed 2014-06-20 | $25.29M derived: sum of 2 quarters · filed 2014-06-20 | $32.50M derived: sum of 3 quarters · filed 2014-06-20 | $38.42M 8-K · filed 2014-06-20 | ||||
| 2011-09-30 | $12.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | $19.46M derived: sum of 2 quarters · filed 2012-10-24 | $25.38M 10-Q · filed 2012-10-24 | $43.62M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-06-30 | $7.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-31 | $13.14M 10-Q · filed 2012-07-31 | $31.38M derived: sum of 3 quarters · filed 2013-02-26 | $38.59M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-03-31 | $5.92M 10-Q · filed 2012-04-26 | -$5.92M 10-Q · filed 2011-04-28 | $24.16M derived: sum of 2 quarters · filed 2013-02-26 | $31.37M derived: sum of 3 quarters · filed 2013-02-26 | $49.00M derived: sum of 4 quarters · filed 2013-02-26 | |||
| 2010-12-31 | $18.24M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $25.45M derived: sum of 2 quarters · filed 2013-02-26 | $43.08M derived: sum of 3 quarters · filed 2013-02-26 | $37.14M 10-K · filed 2013-02-26 | ||||
| 2010-09-30 | $7.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $24.84M derived: sum of 2 quarters · filed 2011-10-31 | $18.90M 10-Q · filed 2011-10-31 | $30.18M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2010-06-30 | $17.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | $11.69M 10-Q · filed 2011-08-01 | $22.98M derived: sum of 3 quarters · filed 2012-02-27 | $28.66M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2010-03-31 | -$5.94M 10-Q · filed 2011-04-28 | $5.34M derived: sum of 2 quarters · filed 2012-02-27 | $11.03M derived: sum of 3 quarters · filed 2012-02-27 | |||||
| 2009-12-31 | $11.29M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $16.97M derived: sum of 2 quarters · filed 2012-02-27 | $25.24M 10-K · filed 2012-02-27 | |||||
| 2009-09-30 | $5.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | $13.95M 10-Q · filed 2010-10-28 | ||||||
| 2009-06-30 | $8.27M 10-Q · filed 2010-07-29 | |||||||
| 2008-12-31 | $13.40M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |